Recombinant Protein
US-2026022387-A1 · Jan 22, 2026 · US
containing a motif for targeting to the periplasmic space of Gram negative bacteria as a soluble protein, i.e. signal sequence should be cleaved
containing a motif for targeting to the periplasmic space of Gram negative bacteria as a soluble protein, i.e. signal sequence should be cleaved · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07K2319/034 |
| Official title | containing a motif for targeting to the periplasmic space of Gram negative bacteria as a soluble protein, i.e. signal sequence should be cleaved |
| Display label | containing a motif for targeting to the periplasmic space of Gram negative bacteria as a soluble protein, i.e. signal sequence should be cleaved |
| Total patents | 45 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is declining.
| Year | Patents |
|---|---|
| 2015 | 4 |
| 2016 | 5 |
| 2017 | 2 |
| 2018 | 4 |
| 2019 | 4 |
| 2020 | 5 |
| 2021 | 6 |
| 2022 | 4 |
| 2023 | 3 |
| 2024 | 4 |
| 2025 | 3 |
| 2026 | 1 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
E. coli for the production of diphtheria toxin polypeptides
US-2025368692-A1 · Dec 4, 2025 · US
Methods and compositions for multivalent vaccines
US-2025152694-A1 · May 15, 2025 · US
E. coli deficient in Lon and SulA for gene targeting
US-12297239-B2 · May 13, 2025 · US
Bioconjugates made from recombinant n-glycosylated proteins from procaryotic cells
US-2024277824-A1 · Aug 22, 2024 · US
Myeloid differentiation factor 2 (MD2) signaling and modulation
US-12054517-B2 · Aug 6, 2024 · US
Methods of producing aggregate-free monomeric diphtheria toxin fusion proteins and therapeutic uses
US-11965009-B2 · Apr 23, 2024 · US
Bioconjugates made from recombinant N-glycosylated proteins from procaryotic cells
US-11944675-B2 · Apr 2, 2024 · US
Systems and methods for the production of diphtheria toxin polypeptides
US-2023331788-A1 · Oct 19, 2023 · US
Systems and methods for the production of diphtheria toxin polypeptides
US-11702456-B2 · Jul 18, 2023 · US
Methods of producing aggregate-free monomeric diphtheria toxin fusion proteins and therapeutic uses
US-2023183307-A9 · Jun 15, 2023 · US
Myeloid differentiation factor 2 (md2) signaling and modulation
US-2022356211-A1 · Nov 10, 2022 · US
Immunogenic composition
US-2022242920-A1 · Aug 4, 2022 · US
Methods of producing aggregate-free monomeric diphtheria toxin fusion proteins and therapeutic uses
US-2022204579-A1 · Jun 30, 2022 · US
Immunogenic composition
US-11286283-B2 · Mar 29, 2022 · US
Methods of producing aggregate-free monomeric diphtheria toxin fusion proteins and therapeutic uses
US-11203626-B2 · Dec 21, 2021 · US
Method for producing fibroin-like protein
US-11117937-B2 · Sep 14, 2021 · US
Immunogenic composition
US-2021214402-A1 · Jul 15, 2021 · US
Methods of producing aggregate-free monomeric diphtheria toxin fusion proteins and therapeutic uses
US-10988512-B2 · Apr 27, 2021 · US
Bioconjugates Made From Recombinant N-Glycosylated Proteins From Procaryotic Cells
US-2021085772-A1 · Mar 25, 2021 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07K2319/034?
- CPC C07K2319/034 is the Cooperative Patent Classification code for “containing a motif for targeting to the periplasmic space of Gram negative bacteria as a soluble protein, i.e. signal sequence should be cleaved.”
- How many patents are filed under CPC C07K2319/034 (containing a motif for targeting to the periplasmic space of Gram negative bacteria as a soluble protein, i.e. signal sequence should be cleaved)?
- Our database includes 45 publications tagged with this CPC code.
- Is patent activity under CPC C07K2319/034 growing?
- Publication counts under this code: 4 in 2024 vs 3 in 2025 (latest complete years).